Hengan International Group (1044) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
19 Aug, 2026Executive summary
Revenue for 1H2026 declined 6.1% YoY to RMB11.09bn, mainly due to intensified competition and promotional pressures, but gross profit margin improved to 35.3% from 32.3% due to premium product growth and lower wood pulp/raw material costs.
Operating profit grew 12.6% YoY to RMB1.98bn, while profit attributable to shareholders fell 8.7% to RMB1.25bn, reflecting higher finance costs and exchange losses.
E-commerce and new retail channel sales grew 4.6% YoY to RMB4.25bn, now accounting for 38.3% of total sales, supporting market share expansion.
Maintained a solid net cash position (RMB6.44bn) and stable interim dividend of RMB0.70 per share.
Market leadership in tissue and hygiene products sustained amid intensified competition.
Financial highlights
Revenue: RMB11.09bn (↓6.1% YoY); core business revenue: RMB9.96bn (↓4.9% YoY).
Gross profit: RMB3.91bn (↑2.7% YoY); gross margin: 35.3% (↑3.0pp YoY).
Operating profit: RMB1.98bn (↑12.6% YoY); profit attributable to shareholders: RMB1.25bn (↓8.7% YoY); basic EPS: RMB1.104 (↓8.5% YoY).
Net cash: RMB6.44bn; gearing ratio: 97.6%; net gearing ratio: -29.4%.
Interim dividend per share: RMB0.70 (unchanged YoY).
Outlook and guidance
Full-year revenue expected to remain stable for hygiene and tissue segments, supported by premiumisation and omni-channel strategies.
Industry consolidation and increased domestic wood pulp supply expected to stabilise costs in 2H2026.
Focus on expanding premium product mix, technological upgrades, ESG integration, and leveraging e-commerce and new retail channels for long-term growth.
Stable raw material prices and supply chain resilience are expected to sustain profitability.
Latest events from Hengan International Group
- Net profit up 10.3% to RMB2.54bn, with strong tissue and e-commerce growth.1044
H2 2025 - Tissue paper growth and e-commerce expansion offset margin pressure from hygiene segment.1044
H1 2025 - Net profit rose 15% to RMB1.41 bn on higher margins and premium product sales.1044
H1 2024 - Revenue and profit fell, but e-commerce and new retail sales rose and dividend was stable.1044
H2 2024